Sidorov J
Dept. of General Internal Medicine, Geisinger Medical Center, Danville, PA 17822-1401.
J Am Geriatr Soc. 1993 May;41(5):498-500. doi: 10.1111/j.1532-5415.1993.tb01884.x.
To study the efficacy of quinine in the prevention of nocturnal leg muscle cramps.
Double-blind, randomized, crossover trial with four periods of observation, each lasting 2 weeks.
General internal medicine outpatient clinic.
Ambulatory outpatients who experienced an estimated two or more typical nocturnal leg cramps per week.
200 mg of quinine taken at bedtime.
Self-reported ratings of leg cramp frequency, duration, and intensity.
Sixteen patients completed the trial. During the 2 weeks patients used quinine, there was no statistically significant reduction in mean leg cramp number (quinine 3.5 vs placebo 4.2, P = 0.48), mean leg cramp duration (quinine 152 seconds vs placebo 163 seconds, P = 0.89), or patient ratings of severity using a 1 (low) to 10 (high) scale (quinine = 4.2 vs placebo = 4.0, P = 0.83).
No significant reduction in nocturnal leg cramp frequency, intensity, or duration could be found using nightly quinine in this study. Since quinine is not without the potential for side effects and drug interactions, clinicians need to carefully consider the likelihood of modest benefit associated with quinine against the potential for side effects and drug-drug interactions.
研究奎宁预防夜间腿部肌肉痉挛的疗效。
双盲、随机、交叉试验,有四个观察期,每期持续2周。
普通内科门诊。
每周估计经历两次或更多次典型夜间腿部痉挛的门诊患者。
睡前服用200毫克奎宁。
自我报告的腿部痉挛频率、持续时间和强度评分。
16名患者完成了试验。在患者使用奎宁的2周内,平均腿部痉挛次数(奎宁组3.5次 vs 安慰剂组4.2次,P = 0.48)、平均腿部痉挛持续时间(奎宁组152秒 vs 安慰剂组163秒,P = 0.89)或患者使用1(低)至10(高)量表的严重程度评分(奎宁组 = 4.2 vs 安慰剂组 = 4.0,P = 0.83)均无统计学显著降低。
在本研究中,每晚使用奎宁未发现夜间腿部痉挛频率、强度或持续时间有显著降低。由于奎宁并非没有副作用和药物相互作用的可能性,临床医生需要仔细权衡奎宁带来适度益处的可能性与副作用及药物相互作用的潜在风险。